Title of article
0-72. Rivizor® versus aminoglutethimide (AG) in the second-line endocrine treatment of postmenopausal patients with advanced breast cancer (ABC) following tamoxifen failure
Author/Authors
Houston S. J.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1997
Pages
2
From page
244
To page
245
Journal title
The Breast
Serial Year
1997
Journal title
The Breast
Record number
453941
Link To Document